Maxim Group Reiterates Buy Rating and $14 PT on Mesoblast Limited (MESO); 'Locking the Database Up for Interim Analysis'
Tweet Send to a Friend
Maxim Group reiterates Buy rating and $14 price target on Mesoblast Limited (NASDAQ: MESO) following the company's announcement the Independent ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
